72.29MMarket Cap
LossP/E TTM
Sangamo Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-05-04The current valuation score of Sangamo Therapeutics Inc is 7.41, ranking 119 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.40, which is -52.82% below the recent high of -0.19 and -893.63% above the recent low of -4.02.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.